Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2026-05-27 Board/Management Inform…
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Directorate change
Board/Management Information Classification · 95% confidence The document is an RNS announcement titled “Directorate change,” reporting that a non-Executive Director has stepped down and an interim chair appointment is made. It contains no financial statements or operational data, but specifically announces a change in the company’s board composition. This fits the definition of Board/Management Information (MANG).
2026-05-27 English
Trading Update
Earnings Release Classification · 85% confidence The document is an RNS announcement titled “Trading Update” by Eden Research plc, providing unaudited revenue, profit before tax, and operational highlights for the period ending 31 March 2026. It is not a full annual or interim report but an earnings/trading update with key financial metrics and forward-looking commentary. This aligns with an Earnings Release (ER) rather than a comprehensive interim report or other category. FY 2026
2026-04-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is a TR-1 notification form detailing a change in major shareholding thresholds (notification of voting rights crossing 3.098%). This is a Major Shareholding Notification under DTR1. Hence, it maps directly to code MRQ.
2026-04-13 English
Completion of Conditional Placing and TVR
Share Issue/Capital Change Classification · 88% confidence The document is an RNS announcement by Eden Research plc announcing the completion of a Conditional Placing, the admission of 190,000,000 new ordinary shares, and updated total voting rights. This is clearly a capital raising event via share issuance. It is not an earnings release or regulatory filing of financial results; nor is it a proxy, management change or AGM material. The most specific category for an announcement of new share issues and resulting capital structure change is Share Issue/Capital Change (SHA).
2026-04-10 English
Satisfaction of Conditions of Conditional Placing
Capital/Financing Update Classification · 85% confidence The document is an RNS (Regulatory News Service) announcement by Eden Research plc confirming that all conditions for a conditional placing have been satisfied. A placing is a share issuance used for fundraising. This announcement provides an update on the company’s financing activity (the conditional placing) rather than detailing an annual report, earnings, or regulatory filing. Therefore it falls under Capital/Financing Update (CAP).
2026-04-08 English
Thymolflex EPA approval
Regulatory Filings Classification · 85% confidence The document is an RNS press release from Eden Research plc announcing EPA approval of their product Thymolflex. It is an operational/regulatory announcement delivered via the London Stock Exchange’s News Service, not a financial report (Annual Report, Interim Report, Earnings Release, etc.) nor a notice of dividend, share issuance, or management change. It falls under general regulatory announcements, making it a Regulatory Filing (RNS).
2026-04-02 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.